Evaluation of Plasmodium vivax HAP2 as a transmission-blocking vaccine candidate

Transmission-blocking vaccine (TBV) is a promising strategy to interfere with the transmission of malaria. To date, only limited TBV candidate antigens have been identified for Plasmodium vivax. HAP2 is a gamete membrane fusion protein, with homology to the class II viral fusion proteins. Herein we...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Vaccine
Päätekijät: Qiu, Yue, Zhao, Yan, Liu, Fei, Ye, Bo, Zhao, Zhenjun, Thongpoon, Sataporn, Roobsoong, Wanlapa, Sattabongkot, Jetsumon, Cui, Liwang, Fan, Qi, Cao, Yaming
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7217802/
https://ncbi.nlm.nih.gov/pubmed/32093983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.02.011
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia